sábado, 11 de junio de 2022

Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients - The Lancet Microbe

Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients - The Lancet Microbe

No hay comentarios:

Publicar un comentario